Bivalirudina Hikma

Bivalirudin is an anticoagulant used to prevent blood clots during medical procedures. This intravenous medication is manufactured by Hikma Farmacêutica (Portugal), S.A. and is commonly used in cardiovascular interventions.

Bivalirudin is primarily used to prevent blood clots during procedures like angioplasty or stent placement. It works by inhibiting the action of thrombin, a key enzyme in blood clotting. This medication is often used in patients undergoing percutaneous coronary intervention (PCI) to reduce the risk of ischemic complications. What is Bivalirudin used for? It is typically administered intravenously to provide rapid and controllable anticoagulation.

Common effects of Bivalirudin may include bleeding at the injection site or prolonged bleeding times. Some individuals might experience bruising or redness at the injection site. These effects are generally mild and resolve once the medication is discontinued. Severe bleeding is rare but requires immediate medical attention.

Bivalirudin should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to monitor blood clotting times regularly during treatment. Patients should inform their healthcare provider about any allergies or other medications they are taking before starting Bivalirudin.

Bivalirudin may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be avoided as it can increase the risk of bleeding. Always consult a healthcare provider before combining Bivalirudin with other medications.